In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Eisai licenses rights to Zonegran from Elan

Executive Summary

Elan Corp. PLC, the original licensee of North American and European rights to Dainippon Pharmaceutical's Zonegran, has transferred these rights to Eisai. Zonegran (zonisamide) is an FDA-approved drug to treat partial seizures in adult epileptic patients.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing (Licensing)

Related Companies